Claret Asset Management Corp Makes New $237,000 Investment in Synopsys, Inc. $SNPS

Claret Asset Management Corp bought a new stake in Synopsys, Inc. (NASDAQ:SNPSFree Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 462 shares of the semiconductor company’s stock, valued at approximately $237,000.

Several other institutional investors have also modified their holdings of SNPS. Saudi Central Bank acquired a new stake in Synopsys during the first quarter worth about $26,000. Clal Insurance Enterprises Holdings Ltd grew its stake in shares of Synopsys by 441.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock valued at $28,000 after buying an additional 53 shares during the period. Independence Bank of Kentucky increased its holdings in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after buying an additional 30 shares during the last quarter. Princeton Global Asset Management LLC raised its position in shares of Synopsys by 481.8% during the 2nd quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 53 shares during the period. Finally, WPG Advisers LLC acquired a new position in Synopsys in the first quarter valued at approximately $34,000. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Bank of America reissued an “underperform” rating and set a $525.00 target price (down previously from $625.00) on shares of Synopsys in a research note on Wednesday, September 10th. Citigroup started coverage on Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 price objective for the company. Wells Fargo & Company reduced their price objective on shares of Synopsys from $550.00 to $445.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 25th. Needham & Company LLC lowered their target price on shares of Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Finally, Morgan Stanley dropped their price target on shares of Synopsys from $715.00 to $510.00 and set an “overweight” rating for the company in a research report on Thursday, September 11th. Ten research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Synopsys currently has a consensus rating of “Hold” and an average target price of $556.33.

Get Our Latest Research Report on SNPS

Insider Activity at Synopsys

In related news, Director Robert G. Painter bought 350 shares of the stock in a transaction that occurred on Thursday, September 11th. The stock was purchased at an average cost of $425.44 per share, with a total value of $148,904.00. Following the purchase, the director directly owned 2,291 shares of the company’s stock, valued at $974,683.04. This trade represents a 18.03% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the sale, the chief accounting officer owned 20,520 shares in the company, valued at approximately $10,278,468. This trade represents a 32.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 19,528 shares of company stock worth $10,066,095. Company insiders own 0.62% of the company’s stock.

Synopsys Trading Up 4.9%

NASDAQ SNPS opened at $438.29 on Tuesday. The firm has a 50 day simple moving average of $438.78 and a 200-day simple moving average of $506.80. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. Synopsys, Inc. has a one year low of $365.74 and a one year high of $651.73. The firm has a market cap of $81.41 billion, a price-to-earnings ratio of 34.40, a PEG ratio of 5.02 and a beta of 1.10.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The business had revenue of $1.74 billion for the quarter, compared to analysts’ expectations of $1.77 billion. During the same period in the previous year, the company earned $3.43 earnings per share. Synopsys’s quarterly revenue was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. Equities research analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.